Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.350
+0.020 (0.60%)
Mar 13, 2025, 4:00 PM EDT - Market closed
Exagen Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Exagen stock have an average target of 7.50, with a low estimate of 7.00 and a high estimate of 8.00. The average target predicts an increase of 123.88% from the current stock price of 3.35.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Exagen stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | +138.81% | Jan 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +108.96% | Jan 3, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +108.96% | May 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +79.10% | Sep 26, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $6 | Buy | Reiterates | $6 | +79.10% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
67.07M
from 55.64M
Increased by 20.54%
Revenue Next Year
75.02M
from 67.07M
Increased by 11.86%
EPS This Year
-0.69
from -0.83
EPS Next Year
-0.45
from -0.69
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 81.3M | 81.3M | 97.5M | ||
| Avg | 67.1M | 75.0M | 88.1M | ||
| Low | 62.2M | 70.6M | 80.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 46.1% | 21.2% | 30.0% | ||
| Avg | 20.5% | 11.9% | 17.5% | ||
| Low | 11.8% | 5.2% | 6.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.47 | -0.35 | -0.44 | ||
| Avg | -0.69 | -0.45 | -0.42 | ||
| Low | -0.81 | -0.58 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.